Alerts
Phage-Microbiome Consortium: Interplay and Modulation in Human Health and Disease
The ISM is pleased to announce the launch of The Phage-Microbiome Consortium.
Aim of the Consortium
The aim of this project is to set up a consortium of experts in the field of bacteriophages and the human microbiome, to collectively explore the potential of phages in shaping and modulating the microbiome in the context of human health and disease. The consortium will work in teams to push the boundaries of current knowledge, through collaborative research and knowledge exchange.
Objectives
1. Understand the Phage-Microbiota Interaction:
The consortium will carry out integrated studies to enhance the understanding of phage-bacteria dynamics and the role of phages in maintaining microbial diversity and stability.
2. Explore the Potential of Phage Therapy:
Teams will investigate the potential of phages as alternative therapeutic agents for various diseases, focusing particularly on conditions associated with microbiome dysbiosis and antibiotic resistance.
3. Identify Phage Biomarkers:
The consortium will work to identify specific changes in phage populations associated with different health conditions, thus facilitating disease prediction, diagnosis, and treatment.
4. Promote Phage Engineering:
With advancements in genetic engineering, the consortium will explore possibilities to create engineered phages with enhanced efficiency, broader spectrums, and other desirable properties.
5. Establish Regulatory and Safety Guidelines:
Recognizing the lack of robust regulatory guidelines for phage therapy, the consortium will also work towards proposing safe and effective guidelines.
What is expected?
The expected outcome of this project is to offer new insights into the complex interplay between phages and the human microbiome and to pave the way for innovative, effective, and personalized phage therapies. By bridging the expertise gap, we aim to leverage the immense potential of phages in treating diseases and promoting human health.
Project Modalities and Application Procedure
To contribute to this Consortium, the ISM requests interested researchers and teams to submit a proposal. Below are the guidelines to respect:
1. Team Formation:
Interested teams should consist of a diverse range of experts with substantial knowledge and experience in bacteriophages, microbiota, or related fields. Each team should ideally have at least one expert in bacteriophages and one in microbiota.
2. Proposal Submission:
Teams should submit a detailed project proposal that outlines their planned research, including objectives, methodologies, expected outcomes, and the timeline for the project. Proposals should demonstrate a clear understanding of the interplay between phages and the microbiome and should propose innovative approaches to explore and modulate this relationship in the context of human health and disease. They should also clearly state how the work contributes to the broader objectives of the consortium.
3. Review Process:
Proposals will be reviewed by a panel of experts in the field. Successful proposals will be selected based on their scientific merit, feasibility, and potential impact on our understanding of the phage-microbiome interplay.
Funding
The consortium will actively seek funding from both private and public institutions to support the selected projects. The collected funding will be distributed to all teams involved in the Consortium.
How to Submit?
Please submit your projects and details above:
- At the following email address: microbiota(at)microbiota-site.com.
- Deadline for the submission: September 1, 2023.
Applications will be reviewed by the Consortium Selection Committee, and successful applicants will be contacted to proceed to the next stage of the process. Please note that acceptance into the consortium is competitive, and only a select number of applicants will be chosen to join.
Role of the International Society of Microbiota
The International Society of Microbiota will act as the principal coordinator and manager of this consortium. The Society will facilitate the integration of teams and will foster the exchange of knowledge and expertise amongst the participants.
In its role as coordinator, the Society will ensure that all projects align with the consortium's overarching goals. It will provide guidance and direction to ensure that research efforts are complementary and additive. The Society will also help in harmonizing data collection and sharing across teams to promote a more comprehensive understanding of the phage-microbiome relationship.
The ISM, will supervise the allocation and utilization of consortium-provided funds, ensuring they are used effectively and efficiently. It will liaise with private and public funding institutions, advocating for the consortium's work and securing additional resources.
Through this central role, the International Society of Microbiota aims to unite global expertise and drive forward the understanding of the pivotal role of phages in modulating the microbiome and influencing human health and disease.
International Society of Microbiota
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Marine Heatwaves and Microbiome in the Mediterranean Sea: Insights From Non Model Organism Manila Clam
Dr. Maria Elena Martino, University of Padova, Italy, will present her latest research during Targeting Microbiota 2023 on October 17-19 in a talk titled "Marine Heatwaves and Microbiome in the Mediterranean Sea: Insights From Non Model Organism Manila Clam".
Extreme climatic events like Marine Heatwaves (MHWs) are becoming more intense and frequent and are severely threatening ecosystems’ health. Specifically, marine ecosystems are facing an increase in the prevalence of pathogenic microbes, causing significant shifts in the ecology and evolution of animal-microbiome symbiosis in marine environments. However, how extreme climate events shape the evolution and the adaptation of marine hosts and their microbiomes is still poorly understood.
Here, Dr. Martino and her team characterized the effect of heat waves on the microbiome of Manila clam Ruditapes philippinarum, one of the most widely farmed clam species worldwide, and investigated the ultimate effect on host health.
You can learn more about Dr. Martino's talk this October in Venice.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Gut microbiota and prebiotics in Parkinson's disease: The RESISTA-PD Trial
Prof. Andreas Schwiertz, Institute of Microecology, Germany will present his latest research during Targeting Microbiota 2023 on October 17-19 in a talk titled "Gut microbiota and prebiotics in Parkinson's disease: The RESISTA-PD Trial".
The composition of the gut microbiome is linked to multiple diseases, including Parkinson’s disease (PD). Bacteria producing short-chain fatty acids (SCFAs) and fecal SCFA concentrations are reduced in PD. SCFAs exert various beneficial functions in humans. In the interventional, monocentric, open-label clinical trial RESISTA-PD Prof. Schwiertz and his colleagues aimed at altering fecal SCFAs by an 8-week prebiotic intervention with resistant starch (RS).
In the PD + RS group, fecal butyrate concentrations increased significantly, and fecal calprotectin concentrations dropped significantly. Clinically, Prof. Schwiertz and his team observed a reduction in non-motor symptom load in the PD+RS group.
About Prof. Prof. Schwiertz
Dr. Andreas Schwiertz is a microbiologist and molecular biologist. He trained at the Carl von Ossietzky University, Oldenburg (GER), the University College Cork (IRL) and Sate University of St. Petersburg (RUS). He received his PhD from the University of Potsdam (GER), where he trained under Prof. Michael Blaut in human gastrointestinal microbiology and on probiotics. In 2012 he received his lecturer qualification from the Justus Liebig University of Giessen on gastrointestinal microbiology where he is associated professor. In 2003 he joined the Institute of Microecology in Herborn, where he serves currently as CEO and CSO.
Join Targeting Microbiota 2023 to learn more about Prof. Schwiertz's talk. You can learn more about Targeting Microbiota 2023 program here.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Computational Modeling Microbial Community Networks: Pros and Cons
Prof. Barbara Di Camillo, University of Padova, Italy will join Targeting Microbiota 2023 on October 17-19 to present her latest research "Computational Modeling Microbial Community Networks: Pros and Cons".
Join Targeting Microbiota 2023 to learn more about Prof. Di Camillo's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Microbiota, Enteric Nervous and Immune Systems: Barrier Defenses against Foodborne Pathogens Carriage in Poultry
Dr. Valentina Caputi, United States Department of Agriculture, Agricultural Research Service, USA, will join Targeting Microbiota 2023 on October 17-19 to present her latest research "Microbiota, Enteric Nervous and Immune Systems: Barrier Defenses against Foodborne Pathogens Carriage in Poultry".
The gastrointestinal tract is the largest body surface in contact with commensal microorganisms (or microbiota) and with pathogens, therefore the intestinal wall possesses a sophisticated system of barriers that protects the host from the translocation of pathogens, their molecular profiles, or environmental toxins in extra-intestinal tissues. The intestinal epithelium provides the first barrier defense against bacterial- or toxins translocation and its function is finely modulated by the immune system. Several studies have explored avian intestinal epithelial barrier alterations following Salmonella or Campylobacter infection. Submucosa and smooth muscle layers are located underneath the intestinal epithelium. These tissues are densely innervated by the enteric nervous system (ENS), a complex network of neurons and glial cells capable of functioning independently from the brain. The ENS is the principal coordinator of gut motility, peristalsis, nutrient absorption, and fluid secretion.
However, recent studies have shown that enteric neuronal populations are responsible for producing proinflammatory cytokines, thus stimulating the intestinal immune cells to release antimicrobial peptides against Salmonella infection in mammals. These results provide evidence of solid neuroimmune interactions in the gut that strengthen the canonical epithelial barrier against pathogenic infections such as Salmonella. The role of enteric neuroimmune interactions in chicken broilers affected by Salmonella or other foodborne pathogens has not been explored yet, and this research will provide a novel approach to understanding foodborne pathogens infection in poultry and ultimately formulate antibiotic alternatives aimed at preserving the integrity and function of the intestinal neuroimmune barriers.
Join Targeting Microbiota 2023 to learn more about Dr. Caputi's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Skin Microbial Changes during Space Flights
Dr. Pamela Tozzo from the University of Padova, Italy will join Targeting Microbiota 2023 on October 17-19 to present her latest research "Skin Microbial Changes during Space Flights".
Join Targeting Microbiota 2023 to learn more about Dr. Tozzo's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Microbiota & Myelinazation: The Latest Findings
Prof. Maria Cecilia Giron, local organizer of Targeting Microbiota 2023, University of Padova, Italy will join the conference and will give a presentation entitled "Microbiota & Myelinazation: The Latest Findings".
Join us in Targeting Microbiota 2023 and benefit from the experience of Prof. Giron. Don't forget that you can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Microbiota, Prophages & Phage Therapy: The Missing Link
Prof. Marvin Edeas Founder & Chairman of ISM's Committee, Institut Cochin, INSERM, Université de Paris, France will join Targeting Microbiota 2023 on October 17-19 to present a talk entitled "Microbiota, Prophages & Phage Therapy: The Missing Link".
Join Targeting Microbiota 2023 to learn more about Prof. Edeas's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
COVID 19 and Microbiota - A Story with a Long Tail
Prof. Peter C. Konturek, President of ISM from Teaching Hospital of the University of Jena, Germany will present a talk entitled "COVID 19 and Microbiota - A Story with a Long Tail".
Join Targeting Microbiota 2023 to learn more about Prof. Konturek's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Evaluation of Transitional Changes Shaping the Infants’ Gut Microbiota in Early Life: The CI.EMME Study
Prof. Vincenzo Di Pilato from the University of Genoa, Italy will join Targeting Microbiota 2023 on October 17-19 to present his latest research "Evaluation of Transitional Changes Shaping the Infants' Gut Microbiota in Early Life: The CI.EMME Study".
The gut microbiota (GM) consists in a densely populated ecosystem that, from birth onwards, colonizes the intestinal tract through a highly dynamic processes, fundamental for health later in life. Indeed, disturbance of the GM in early life may results in lifelong consequences, and certain microbial features can be associated with disease states that are manifested at later stages, including asthma, inflammatory bowel disease, and metabolic disorders.
In the context of the CI.EMME study, Prof. Di Pilato and his team, longitudinally investigated the transitional changes of GM in a cohort of infants, expanding knowledge about the microbiota composition and maturation paths in early life.
Join Targeting Microbiota 2023 to learn more about Prof. Di Pilato's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Mapping the Kitchen Microbiota in Five European Countries
Dr. Birgitte Moen from Nofima—Norwegian Institute of Food, Fisheries and Aquaculture Research, Norway will join Targeting Microbiota 2023 on October 17-19 to present her latest research "Mapping the Kitchen Microbiota in Five European Countries".
Join Targeting Microbiota 2023 to learn more about Dr. Moen's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Microbiome Engineering: Reprograming microbes to rewire host-microbiome interactions
Dr. Matthew Chang from the National University of Singapore, Singapore will join the Targeting Microbiota 2023 congress and will talk about "Microbiome Engineering: Reprograming microbes to rewire host-microbiome interactions".
The wealth of knowledge on the human microbiota composition and its roles in health and disease has recently spurred the development of novel therapeutic strategies. Moreover, with an array of genetic tools that are readily available, programmable genetic circuits can be designed, genomes can be edited and rewritten, and cells can be reprogrammed to foster novel microbiota-based interventions.
In this talk, Dr. Chang's recent work on engineering gut-resident microbes as versatile platforms equipped with clinically relevant functionalities will be presented. A particular emphasis will be placed on his team's efforts to transform gut microbes into live biotherapeutics with prophylactic and therapeutic efficacy against pathogenic infections and chronic metabolic diseases.
This work provides a strong foundation for engineering microbes to modulate host-microbiome interactions and supports the use of live biotherapeutics as a viable strategy for clinical intervention.
About Dr. Chang
Matthew Chang is Director of the National Centre for Engineering Biology, Singapore Consortium for Synthetic Biology, Wilmar-NUS Corporate Laboratory, and NUS Synthetic Biology for Clinical and Technological Innovation, and Dean’s Chair in Medicine and Associate Professor of Biochemistry and Synthetic Biology at the Yong Loo Lin School of Medicine at the National University of Singapore. His research focuses on studying the engineering of biology to develop autonomous, programmable cells for biomedical and biomanufacturing applications. He co-founded the Global Biofoundry Alliance and the Asian Synthetic Biology Association and serves as Co-Chair of the World Economic Forum’s Global Future Council on Synthetic Biology.
Join Targeting Microbiota 2023 to learn more about Dr. Chang's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Environmental Drivers of Avian Enteric Neuroendocrine Plasticity in the Context of Foodborne Pathogen Carriage
Dr. Joshua Lyte, United States Department of Agriculture, Agricultural Research Service, USA, will join the Targeting Microbiota 2023 congress to talk about: "Environmental Drivers of Avian Enteric Neuroendocrine Plasticity in the Context of Foodborne Pathogen Carriage".
Environmental pressures represent an omnipresent threat across the diverse phases of poultry production in the 21st century. Research directed at mitigating the deleterious effects of environmental stress on the avian gastrointestinal tract necessitates the identification of mechanistic pathways that sit at the nexus of host and microbiota.
The research approach that Dr. Lyte and his team employed has its basis in common mechanistic pathways that are shared among diverse forms of environmental stressors. Those pathways principally involve the host’s neuroendocrine response to stress as well as the response of the gut microbiota whose composition and function are critical to gut homeostasis and avian well-being.
Microbial endocrinology, which is the study of the intersection of two seemingly disparate fields, neuroendocrine physiology and microbiology, and the bi-directional communication between both, that is at the core of our approach to devising new strategies to combat environmental stressors in food production animals. The remarkable integration of the bird’s neuroendocrine physiology and its microbiota is due to the evolutionary-based fact that each shares a range of neurochemicals, principally those related to the stress response, that permit bi-directional communication between the two that ultimately influences host gut function.
This talk will focus on the avian gut as the anatomical region where the host and microbiota interact and represents the area that can most easily be leveraged to deal with environmental stressors. As will be discussed, the design of new antibiotic alternative strategies that seek to manage the intersection of host neuroendocrine physiology and microbiota is one of the most promising avenues for dealing with the negative effects of environmental stress which may drive avian susceptibility to foodborne pathogen carriage.
Join Targeting Microbiota 2023 to learn more about Dr. Lyte's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Effect of Gut Microbiota Regulation on Non-Alcoholic Fatty Liver Disease
Dr. Yu Chen from The 7th Affiliated Hospital of Southern Medical University, China will join the Targeting Microbiota 2023 congress to talk about: "Effect of Gut Microbiota Regulation on Non-Alcoholic Fatty Liver Disease".
Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent cause of chronic liver disease. Alteration of the microbiota seem to be key in the development and progression of NAFLD. Gut microbiome regulation, such as Faecal Microbiota Transplantation (FMT) and supplementation in Akkermansia muciniphila , was paving the way as the therapeutic target for NAFLD.
Join Targeting Microbiota 2023 to learn more about Dr. Chen's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Gut Microbiota & Microbiota-Derived Metabolites Role in Endometriosis
Dr. Ramakrishna Kommagani from Baylor College of Medicine, USA will join the Targeting Microbiota 2023 congress to talk about: "Gut Microbiota & Microbiota-Derived Metabolites Role in Endometriosis".
Join Targeting Microbiota 2023 to learn more about Dr. Kommagani's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Domestic Cleaning and Human Microbiome - Is There a Link?
Prof. Markus Egert from Furtwangen University and active member of the ISM scientific committee, will chair a session on "Environment, Lifestyle & Microbiota: A "One Health" Approach" during Targeting Microbiota 2023.
In industrialized countries, people spend up to 90% of their lifetime indoors. However, potential links between the indoor microbiome, the microbiome of daily used objects, the human microbiome and health and well-being are only poorly understood.
Prof. Egert will present a talk that will summarize current knowledge about how domestic cleaning and hygiene measures, predominantly aiming at the prevention of infectious diseases, might influence and shape the human microbiome and its effects on human health. His talk will conclude with suggestions on what "microbiome-friendly" household hygiene could look like.
Prof. Egert's talk will be titled: "Domestic Cleaning and Human Microbiome - Is There a Link?"
About Prof. Egert
Markus Egert is professor for Microbiology and Hygiene at Furtwangen University of Applied Sciences (Black Forest, Germany). His work aims at a deeper understanding of the structural and functional interactions of microbial communities with humans. He was one of the first researchers to apply the so-called RNA-based stable isotope probing technique (RNA-SIP) to intestinal ecosystem in order to identify prebiotics-degrading bacteria. In addition, he is known for his pioneering work on the microbiome of objects of daily use, such as kitchen sponges, spectacles and washing machines, and the hygienic relevance that goes with it.
Join Targeting Microbiota 2023 to learn more about Prof. Egert's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Microbiota and Interactions with Gut and the Enteric Nervous System
Prof. Karl-Herbert Schäfer from Kaiserlautern University of Applied Sciences, Germany will join the Targeting Microbiota 2023 congress to talk about: "Microbiota and Interactions with Gut and the Enteric Nervous System".
The gut contains billions of bacteria, that have long been neglected, and which have been seen, at best, as potential trouble makers in cases of diseases. During the last decades, the view of the enteric microbiome changed a lot. It is known now that it is influencing the quality of the gut barrier, producing legions of metabolites that influence both gut and enteric nervous system, changing i.e. gut motility or the inflammatory status of the gut wall.
Bacterial lipopolysaccharides might immediately impact i.e. the proliferation of neural stem cells within the ENS, or influence their differentiation. Bacteria can produce neurotransmitters such as GABA and serotonin, along with short chain fatty acids (SCFA) such as butyrate. Extracellular vesicles, produced by the bacteria, can carry this molecules along the mucosal barrier and might influence directly the activity of the ENS and thus the whole gut. Moreover, bacteria can produce Amyloid-like Protein Fibrils (ALFs) such as curli, which might initiate pathological processes in neurodegenerative diseases.
The impact of individual bacterial strains or LPS as a major molecule provided by gram negative bacteria upon gut and ENS has been investigated by Prof. Schäfer and his colleagues using primary cultures of the isolated myenteric plexus, analysing its growth or electrical responses after “bacterial” stimulation. Whole gut segments have been used in organ bath approaches to investigate alterations of gut motility when being perfused with bacteria or bacterial supernatants.
Join Targeting Microbiota 2023 to learn more about Prof. Schäfer's research and obtained data.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Arresting microbiome development limits immune system maturation and resistance to infection in mice
Dr. Michael Silverman from the University of Pennsylvania, USA will join the Targeting Microbiota 2023 congress and will talk about "Arresting microbiome development limits immune system maturation and resistance to infection in mice".
Join Targeting Microbiota 2023 to learn more about Dr. Silverman's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Engineered Escherichia Coli for the in Situ Secretion of Therapeutic Nanobodies in the Gut
Dr. Cammie Lesser from Massachusetts General Hospital, Harvard Medical School, will join Targeting Microbiota 2023 on October 17-19 to present her latest research "Engineered Escherichia Coli for the in Situ Secretion of Therapeutic Nanobodies in the Gut".
Dr. Lesser will elaborate on the development of PROT3EcT, a platform of commensal and probiotic E. coli outfitted with a programmable secretion system. PROT3EcT can secrete functional single-domain antibodies (nanobodies), high-specificity therapeutics, into its surroundings. TNF-PROT3EcT, a variant that secretes TNF-alpha neutralizing nanobodies is as efficacious as systematically administered anti-TNF-alpha neutralizing monoclonal antibodies in inhibiting the development of colitis in a preclinical mouse model of Inflammatory Bowel Disease.
About Dr. Lesser
Dr. Lesser is a physician-scientist whose lab is interested in deciphering the ways that bacterial pathogens manipulate host cells to promote their own survival and dissemination. She has a long-standing interest in studying the pathogenesis of Shigella flexneri, focusing on its type III secretion system, a complex nanomachine that it uses to inject over 30 different proteins into human host cells. Projects in her lab focus on understanding how type III secreted proteins are defined as substrates, deciphering how they act to manipulate eukaryotic host cell processes, and most recently in engineering these secretion systems to develop engineered E. coli as a therapeutic protein delivery platform.
Join Targeting Microbiota 2023 to learn more about Dr. Lesser's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Multi-omics in Colon Cancer and Role of the Microbiome
Dr. Souhaila Al Khodor from Sidra Medicine, Qatar will join the Targeting Microbiota 2023 congress to talk about: "Multi-omics in Colon Cancer and Role of the Microbiome".
This study consisted of 348 treatment-naïve patients with colon cancer that were profiled using various omics including 16S rRNA gene sequencing and complemented with tumor whole-genome sequencing for further microbiome analysis. Dr. Al Khodor and her team characterized the immune-microbiota interactions in those patients and identified microbial signatures predictive of overall survival.
They identified a microbiome signature, driven by Ruminococcus bromii, that was associated with a favorable outcome. This study is a step forward toward implementing microbiota-targeting approaches, such as dietary intervention in the adjuvant or neoadjuvant setting.
Join Targeting Microbiota 2023 to learn more about Dr. Khodor's talk.
You can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
Clinical Applications of Gut Microbiota: Gut Microbiome for Prediction of Colorectal Neoplasia
Dr. Francis K L Chan from The Chinese University of Hong Kong, China will join the Targeting Microbiota 2023 congress and will give a speech entitled "Clinical Applications of Gut Microbiota: Gut Microbiome for Prediction of Colorectal Neoplasia".
Join us in Targeting Microbiota 2023 and benefit from the experience of Dr. Chan. Don't forget that you can share your related work by submitting your abstract.
Targeting Microbiota 2023 Congress
October 17-19, 2023 - Venice
Linkedin | Facebook | Website
